Annual EBIT:
-$153.46M-$124.73M(-434.17%)Summary
- As of today, IMNM annual earnings before interest & taxes is -$153.46 million, with the most recent change of -$124.73 million (-434.17%) on December 31, 2024.
- During the last 3 years, IMNM annual EBIT has fallen by -$128.25 million (-508.86%).
- IMNM annual EBIT is now -1891.90% below its all-time high of -$7.70 million, reached on December 31, 2018.
Performance
IMNM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$60.14M-$13.66M(-29.39%)Summary
- As of today, IMNM quarterly earnings before interest & taxes is -$60.14 million, with the most recent change of -$13.66 million (-29.39%) on September 30, 2025.
- Over the past year, IMNM quarterly EBIT has dropped by -$16.32 million (-37.25%).
- IMNM quarterly EBIT is now -2165.08% below its all-time high of -$2.65 million, reached on March 31, 2020.
Performance
IMNM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$206.85M-$16.32M(-8.57%)Summary
- As of today, IMNM TTM earnings before interest & taxes is -$206.85 million, with the most recent change of -$16.32 million (-8.57%) on September 30, 2025.
- Over the past year, IMNM TTM EBIT has increased by +$103.93 million (+33.44%).
- IMNM TTM EBIT is now -7504.78% below its all-time high of -$2.72 million, reached on September 30, 2019.
Performance
IMNM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IMNM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -434.2% | -37.3% | +33.4% |
| 3Y3 Years | -508.9% | -604.7% | -459.7% |
| 5Y5 Years | -1384.4% | -2034.1% | -2426.3% |
IMNM EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -508.9% | at low | -1245.1% | +54.5% | -812.7% | +33.4% |
| 5Y | 5-Year | -1384.4% | at low | -2034.1% | +54.5% | -2426.3% | +33.4% |
| All-Time | All-Time | -1891.9% | at low | -2165.1% | +54.5% | -7504.8% | +33.4% |
IMNM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$60.14M(-29.4%) | -$206.85M(-8.6%) |
| Jun 2025 | - | -$46.48M(-4.1%) | -$190.53M(-3.5%) |
| Mar 2025 | - | -$44.64M(+19.7%) | -$184.06M(+32.3%) |
| Dec 2024 | -$153.46M(-434.2%) | -$55.60M(-26.9%) | -$271.72M(+12.6%) |
| Sep 2024 | - | -$43.82M(-9.5%) | -$310.78M(-14.4%) |
| Jun 2024 | - | -$40.01M(+69.8%) | -$271.59M(-14.4%) |
| Mar 2024 | - | -$132.30M(-39.8%) | -$237.36M(-116.7%) |
| Dec 2023 | -$28.73M(+22.1%) | -$94.65M(-1943.0%) | -$109.53M(-383.3%) |
| Sep 2023 | - | -$4.63M(+19.7%) | -$22.66M(+14.7%) |
| Jun 2023 | - | -$5.77M(-29.1%) | -$26.57M(+10.6%) |
| Mar 2023 | - | -$4.47M(+42.6%) | -$29.72M(+19.5%) |
| Dec 2022 | -$36.90M | -$7.79M(+8.8%) | -$36.90M(+0.2%) |
| Sep 2022 | - | -$8.53M(+4.4%) | -$36.96M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$8.93M(+23.4%) | -$36.15M(-9.7%) |
| Mar 2022 | - | -$11.65M(-48.6%) | -$32.96M(-30.8%) |
| Dec 2021 | -$25.20M(-41.6%) | -$7.84M(-1.6%) | -$25.20M(-17.6%) |
| Sep 2021 | - | -$7.72M(-34.5%) | -$21.43M(-29.7%) |
| Jun 2021 | - | -$5.74M(-47.3%) | -$16.53M(-22.4%) |
| Mar 2021 | - | -$3.90M(+4.3%) | -$13.50M(-10.1%) |
| Dec 2020 | -$17.80M(-72.2%) | -$4.07M(-44.5%) | -$12.26M(-49.7%) |
| Sep 2020 | - | -$2.82M(-3.8%) | -$8.19M(-1.2%) |
| Jun 2020 | - | -$2.71M(-2.3%) | -$8.09M(-50.5%) |
| Mar 2020 | - | -$2.65M(+2.4%) | -$5.38M(-97.6%) |
| Dec 2019 | -$10.34M(-34.2%) | - | - |
| Sep 2019 | - | -$2.72M | -$2.72M |
| Dec 2018 | -$7.70M | - | - |
FAQ
- What is Immunome, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Immunome, Inc.?
- What is Immunome, Inc. annual EBIT year-on-year change?
- What is Immunome, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Immunome, Inc.?
- What is Immunome, Inc. quarterly EBIT year-on-year change?
- What is Immunome, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Immunome, Inc.?
- What is Immunome, Inc. TTM EBIT year-on-year change?
What is Immunome, Inc. annual earnings before interest & taxes?
The current annual EBIT of IMNM is -$153.46M
What is the all-time high annual EBIT for Immunome, Inc.?
Immunome, Inc. all-time high annual earnings before interest & taxes is -$7.70M
What is Immunome, Inc. annual EBIT year-on-year change?
Over the past year, IMNM annual earnings before interest & taxes has changed by -$124.73M (-434.17%)
What is Immunome, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of IMNM is -$60.14M
What is the all-time high quarterly EBIT for Immunome, Inc.?
Immunome, Inc. all-time high quarterly earnings before interest & taxes is -$2.65M
What is Immunome, Inc. quarterly EBIT year-on-year change?
Over the past year, IMNM quarterly earnings before interest & taxes has changed by -$16.32M (-37.25%)
What is Immunome, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of IMNM is -$206.85M
What is the all-time high TTM EBIT for Immunome, Inc.?
Immunome, Inc. all-time high TTM earnings before interest & taxes is -$2.72M
What is Immunome, Inc. TTM EBIT year-on-year change?
Over the past year, IMNM TTM earnings before interest & taxes has changed by +$103.93M (+33.44%)